Inhibition of the glutaredoxin and thioredoxin systems and ribonucleotide reductase by mutant p53-targeting compound APR-246
Abstract The tumor suppressor p53 is commonly inactivated in human tumors, allowing evasion of p53-dependent apoptosis and tumor progression. The small molecule APR-246 (PRIMA-1Met) can reactive mutant p53 in tumor cells and trigger cell death by apoptosis. The thioredoxin (Trx) and glutaredoxin (Gr...
Guardado en:
Autores principales: | Lena Haffo, Jun Lu, Vladimir J. N. Bykov, Sebastin S. Martin, Xiaoyuan Ren, Lucia Coppo, Klas G. Wiman, Arne Holmgren |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5919892998d44e63a8772d90b40e9d3a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Convergent allostery in ribonucleotide reductase
por: William C. Thomas, et al.
Publicado: (2019) -
Methylselenol formed by spontaneous methylation of selenide is a superior selenium substrate to the thioredoxin and glutaredoxin systems.
por: Aristi P Fernandes, et al.
Publicado: (2012) -
Transketolase regulates sensitivity to APR-246 in p53-null cells independently of oxidative stress modulation
por: Julia V. Milne, et al.
Publicado: (2021) -
Acetylation regulates ribonucleotide reductase activity and cancer cell growth
por: Guo Chen, et al.
Publicado: (2019) -
Biofilm modifies expression of ribonucleotide reductase genes in Escherichia coli.
por: Maria del Mar Cendra, et al.
Publicado: (2012)